Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Pharmaceuticals industria. La empresa tiene su sede en Nashville, DE, United States. El CEO actual es Mark L. Baum.
HROWL tiene fecha de IPO 2021-05-07, 217 empleados a tiempo completo, cotiza en el NASDAQ Global Market, una capitalización de mercado de $1.37B.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
